top of page

"Team science is the way to go:" Dr. Nora Disis Featured in Healthcare Unfiltered Podcast

  • Writer: Sarah White
    Sarah White
  • 5 days ago
  • 1 min read

"We'd really like to see the science of oncology more, again through that lens of what is really going to make the difference for the patient in the next five years."


That's the standard that Dr. Nora Disis is setting.


In Episode 267 of Healthcare Unfiltered, Dr. Disis, Director of the Cancer Vaccine Institute (CVI), Editor-In-Chief of Jama Oncology, and Deputy Editor of JAMA, shares her vision for the future of medical publishing with Dr. Chadi Nabhan. She discusses the evolving state of peer review, how publishing must adapt as science accelerates, and what it takes to maintain rigor while focusing on patient care.


As oncology science moves faster than ever, peer review is under strain. The stakes are higher, making it even more crucial to find the right reviewers.


"You know, and I know, how much oncology treatment has changed in the last 20 years," Dr. Disis says. "Cancers that used to kill us aren't killing us, and it's all about the science that has changed the way we treat cancer. We know the science, immuno-oncology, and targeted therapies that totally changed the last decade."


These breakthroughs made it into practice because they were vetted carefully. The integrity of the review process matters. The choice of the reviewers matters. The editorial lens matters.


"That's what you're going to see in JAMA Oncology: the science that's going to change the next decade of treatment."


Post: Blog2_Post
bottom of page